NasdaqCM - Nasdaq Real Time Price USD

Avalo Therapeutics, Inc. (AVTX)

10.60 -0.22 (-2.03%)
At close: May 14 at 4:00 PM EDT
10.54 -0.06 (-0.57%)
After hours: May 14 at 7:48 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,924.00
1,924.00
18,051.00
5,398.00
6,699.00
Cost of Revenue
1,284.00
1,284.00
3,434.00
1,491.00
300.00
Gross Profit
640.00
640.00
14,617.00
3,907.00
6,399.00
Operating Expense
24,084.00
24,084.00
52,057.00
86,041.00
53,693.00
Operating Income
-23,444.00
-23,444.00
-37,440.00
-82,134.00
-47,294.00
Net Non Operating Interest Income Expense
-3,417.00
-3,417.00
-4,170.00
-2,391.00
49.00
Other Income Expense
-4,669.00
-4,669.00
-20.00
-20.00
-19,932.00
Pretax Income
-31,530.00
-31,530.00
-41,630.00
-84,545.00
-67,177.00
Tax Provision
14.00
14.00
28.00
-196.00
-2,793.00
Net Income Common Stockholders
-31,544.00
-31,544.00
-41,658.00
-84,376.00
-57,638.00
Diluted NI Available to Com Stockholders
-31,544.00
-31,544.00
-41,658.00
-84,376.00
-57,638.00
Basic EPS
-114.00
-114.00
-1.06k
-2.39k
-2.48k
Diluted EPS
-114.00
-114.00
-1.06k
-2.39k
-2.48k
Basic Average Shares
277.73
277.73
39.20
35.30
1,283.19
Diluted Average Shares
277.73
277.73
39.20
35.30
1,283.19
Total Expenses
25,368.00
25,368.00
55,491.00
87,532.00
53,993.00
Net Income from Continuing & Discontinued Operation
-31,544.00
-31,544.00
-41,658.00
-84,376.00
-63,500.00
Normalized Income
-27,888.67
-27,888.67
-41,658.00
-84,349.00
-44,899.36
Interest Income
--
--
--
--
48.87
Interest Expense
3,417.00
3,417.00
4,170.00
2,391.00
--
Net Interest Income
-3,417.00
-3,417.00
-4,170.00
-2,391.00
49.00
EBIT
-28,113.00
-28,113.00
-37,460.00
-82,154.00
-47,294.00
EBITDA
-27,955.00
-27,955.00
-37,294.00
-80,497.00
-45,451.00
Reconciled Cost of Revenue
1,126.00
1,126.00
3,306.00
1,382.00
198.00
Reconciled Depreciation
158.00
158.00
166.00
1,657.00
1,843.00
Net Income from Continuing Operation Net Minority Interest
-31,544.00
-31,544.00
-41,658.00
-84,349.00
-64,384.00
Total Unusual Items Excluding Goodwill
-4,627.00
-4,627.00
--
--
-20,341.00
Total Unusual Items
-4,627.00
-4,627.00
--
--
-20,341.00
Normalized EBITDA
-23,328.00
-23,328.00
-37,294.00
-80,497.00
-25,110.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-971.67
-971.67
--
--
-856.36
12/31/2020 - 10/14/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BDRX Biodexa Pharmaceuticals Plc
1.1000
+13.99%
 
TPST Tempest Therapeutics, Inc.
3.4000
+3.66%
 
ALLR Allarity Therapeutics, Inc.
0.7885
-0.94%
 
PXMD PaxMedica, Inc.
0.2070
-9.53%
 
TCBP TC Biopharm (Holdings) Plc
1.1500
+1.77%
 
ENVB Enveric Biosciences, Inc.
0.8205
-3.41%
 
ADIL Adial Pharmaceuticals, Inc.
1.4400
-0.35%
 
IBIO iBio, Inc.
1.8800
+3.56%
 
ATXI Avenue Therapeutics, Inc.
3.8400
-2.78%
 
CYCC Cyclacel Pharmaceuticals, Inc.
2.8400
+11.81%